ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,487.03
      0.25%
      US Tech 100
      19,430.40
      0.14%
      Dow Jones
      38,834.86
      0.15%
      Brent Oil
      84.695
      -0.11%
      Bitcoin
      65,036.39
      -0.16%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Inovio Pharmaceuticals Inc New (INO)

      7. Inovio Pharmaceuticals Inc New (INO) News

      INO

      Inovio Pharmaceuticals (INO)

      Inovio Pharmaceuticals Inc New
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:INO
      DateTimeSourceHeadlineSymbolCompany
      05/11/20225:04PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INOInovio Pharmaceuticals Inc New
      05/11/202212:05PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:INOInovio Pharmaceuticals Inc New
      05/10/20224:34PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INOInovio Pharmaceuticals Inc New
      05/10/20224:05PMPR Newswire (US)INOVIO Announces the Appointment of Jacqueline Shea, Ph.D., as Chief Executive OfficerNASDAQ:INOInovio Pharmaceuticals Inc New
      05/10/20224:05PMPR Newswire (US)INOVIO Reports First Quarter 2022 Financial Results and Program DevelopmentsNASDAQ:INOInovio Pharmaceuticals Inc New
      04/26/20228:00AMPR Newswire (US)INOVIO to Report First Quarter 2022 Financial Results on May 10, 2022NASDAQ:INOInovio Pharmaceuticals Inc New
      03/28/20224:06PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INOInovio Pharmaceuticals Inc New
      03/25/20224:29PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:INOInovio Pharmaceuticals Inc New
      03/24/20223:00AMPR Newswire (US)Geneos Therapeutics Secures $17 Million in Series A2 Financing to Advance Personalized Cancer Immunotherapy PlatformNASDAQ:INOInovio Pharmaceuticals Inc New
      03/22/20224:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INOInovio Pharmaceuticals Inc New
      03/17/20224:04PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INOInovio Pharmaceuticals Inc New
      03/14/20224:47PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INOInovio Pharmaceuticals Inc New
      03/09/20224:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INOInovio Pharmaceuticals Inc New
      03/08/20228:00AMPR Newswire (US)INOVIO to Present at Oppenheimer's 32nd Annual Healthcare ConferenceNASDAQ:INOInovio Pharmaceuticals Inc New
      03/04/20226:27PMTipRanksHas the Covid Opportunity Been and Gone for Inovio? Oppenheimer Weighs InNASDAQ:INOInovio Pharmaceuticals Inc New
      03/01/20224:05PMPR Newswire (US)INOVIO Reports Fourth Quarter 2021 and Year-End Financial ResultsNASDAQ:INOInovio Pharmaceuticals Inc New
      02/15/20228:00AMPR Newswire (US)INOVIO to Report Fourth Quarter and Year-End 2021 Financial Results on March 1, 2022NASDAQ:INOInovio Pharmaceuticals Inc New
      02/10/20228:29AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:INOInovio Pharmaceuticals Inc New
      02/01/20225:15PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:INOInovio Pharmaceuticals Inc New
      01/21/20224:03PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INOInovio Pharmaceuticals Inc New
      01/18/20224:06PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INOInovio Pharmaceuticals Inc New
      01/05/20224:04PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INOInovio Pharmaceuticals Inc New
      12/30/20213:49PMTipRanksIs 15% Potential Upside Good Enough to Risk Buying Inovio Stock? Analyst Weighs InNASDAQ:INOInovio Pharmaceuticals Inc New
      12/15/20217:12PMTipRanksInovio: Making Progress in the Cervical HSIL ProgramNASDAQ:INOInovio Pharmaceuticals Inc New
      12/14/20218:00AMPR Newswire (US)INOVIO Highlights Key Updates on Phase 3 Program for VGX-3100, its DNA-based Immunotherapy for the Treatment of Cervical HSIL Caused by HPV-16 and/or HPV-18NASDAQ:INOInovio Pharmaceuticals Inc New
      11/30/20218:00AMPR Newswire (US)INOVIO Announces Strategy to Address Omicron (B.1.1.529) and Future SARS-CoV-2 VariantsNASDAQ:INOInovio Pharmaceuticals Inc New
      11/16/20218:00AMPR Newswire (US)INOVIO Collaborates with GuardRX and Geneva University Hospitals for Heterologous Booster Clinical Trial of its Ebola DNA Vaccine Candidate, INO-4201NASDAQ:INOInovio Pharmaceuticals Inc New
      11/15/20218:00AMPR Newswire (US)INOVIO to Give Eight Presentations at the 34th International Papillomavirus ConferenceNASDAQ:INOInovio Pharmaceuticals Inc New
      11/12/20216:22PMTipRanksInovio Stock at $35 a Share? This Analyst Thinks It’s PossibleNASDAQ:INOInovio Pharmaceuticals Inc New
      11/09/20214:51PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:INOInovio Pharmaceuticals Inc New
       Showing the most relevant articles for your search:NASDAQ:INO